Comparison of bioavailability of two dipyridamole formulations
Markiewicz, A.; Semenowicz, K.; Szczyrba, E.; Kocek, B.
Polish Journal of Pharmacology and Pharmacy 30(5): 605-609
1978
ISSN/ISBN: 0301-0244 PMID: 582068 Document Number: 135304
The experiment carried out on 6 volunteers shows a better bioavailability of a 75 mg single oral dose of Persantin (Boehringer) than of the same dose of Curantyl (Germed). The difference is due to the manner in which the dragées are manufactured: the bioavailability of both preparations was the same when the dragées were pulverized before oral administration.
Document emailed within 1 workday
Related Documents
Terhaag, B.; Donath, F.; Le Petit, G.; Feller, K. 1986: The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison International Journal of Clinical Pharmacology Therapy and Toxicology 24(6): 298-302Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Woodford, R.; Barry, B.W. 1974: Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay Current Therapeutic Research 16(4): 338-345
Cano, J.P.; Soliva, M.; Hartmann, D.; Ziegler, W.H.; Amrein, R. 1977: Bioavailability from various galenic formulations of flunitrazepam Arzneimittel-Forschung 27(12): 2383-2388
Verbesselt, R.; Tjandramaga, T.B.; Mullie, A.; De Schepper, P.J. 1978: Comparative bioavailability of two acebutolol formulations Bollettino Chimico Farmaceutico 117(2): 102-106
Gafiţanu, E.; Dumistrăcel, I.; Antochi, S. 1991: Formulations and bioavailability of propyphenazone in lyophilized tablets Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 95(1-2): 127-128
Bousquet, E.; Tirendi, S.; Bonina, F.P.; Montenegro, L.; Bianchi, A.; Ciampini, N. 1992: Bioavailability of two formulations of acetylsalicylic acid gums Die Pharmazie 47(8): 607-609
Franke, G.; Diletti, E.; Hoffmann, C.; Zschiesche, M.; Scheuch, E.; Siegmund, W. 1995: Relative bioavailability of different valproic acid formulations International Journal of Clinical Pharmacology and Therapeutics 33(12): 653-657
González-Peñas, E.; Echeverría, H.C.; Mosquera, J.; Esteras, A.; Bruseghini, L. 2003: Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit Arzneimittel-Forschung 53(11): 786-792
Trejo, D.; Toledo, A.; Carrasco-Portugal, M.d.C.; Aguilar-Cota, M.ía.E.; Herrera, J.E.; Flores-Murrieta, F.J. 2003: Comparative bioavailability of two oral formulations of ciprofloxacin Proceedings of the Western Pharmacology Society 46: 134-135
Lapka, R.; Cepeláková, H.; Rejholec, V.; Franc, Z. 1986: Bioavailability of two oral formulations of triazolam using radioreceptor assay Die Pharmazie 41(4): 256-257
De Caro, G.; Maggi, L. 1984: Bioavailability in man of oral formulations of flunarizine (drops and capsules) Bollettino Chimico Farmaceutico 123(10): 65S-70S
Lintz, W.; Barth, H.; Osterloh, G.; Schmidt-Böthelt, E. 1986: Bioavailability of enteral tramadol formulations. 1st communication: capsules Arzneimittel-Forschung 36(8): 1278-1283
Ba, B.B.; Iliadis, A.; Durand, A.; Berger, Y.; Cano, J.P. 1988: New approach in bioavailability study of two formulations of ethyl loflazepate Arzneimittel-Forschung 38(10): 1486-1489
Chopra, R.K.; Goldman, R.; Sinatra, S.T.; Bhagavan, H.N. 1998: Relative bioavailability of coenzyme Q10 formulations in human subjects International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 68(2): 109-113
Hespe, W.; Verschoor, J.S.; Olthoff, M. 1987: Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics Arzneimittel-Forschung 37(3): 372-375
Metwally, A.; Bennett, J.L.; Botros, S.; Ebeid, F. 1995: Effect of cimetidine, bicarbonate and glucose on the bioavailability of different formulations of praziquantel Arzneimittel-Forschung 45(4): 516-518
Muscará, M.N.; De Nucci, G. 1991: Bioavailability of four pharmaceutical formulations of metronidazole tested on normal healthy volunteers Brazilian Journal of Medical and Biological Research 24(12): 1251-1260
Riaz, H.; Goodman, B.; Bashir, S.; Hussain, S.; Mahmood, S.; Malik, F.; Waseem, D.; Raza, S.A.; Mahmood, W.; Alamgeer 2016: Comparative Bioavailability Analysis of Oral Alendronate Sodium Formulations in Pakistan Acta Poloniae Pharmaceutica 73(4): 999-1007
Gielsdorf, W.; Nieder, M.; Molz, K.H.; Jaeger, H.; Haerlin, R.; Radtke, H.W. 1986: The pharmacokinetics and bioavailability of urapidil. in vitro/in vivo correlations of different experimental formulations Arzneimittel-Forschung 36(8): 1265-1267